流感疫苗接种与急性心肌梗死风险:基于人群的病例对照研究
流感疫苗接种者AMI风险调整OR为0.85(95%CI 0.82-0.88),三个流行期均显示保护性关联,肺炎球菌疫苗无此关联。结论提示流感疫苗对AMI有中度保护作用,但可能受未测量混杂因素影响。
要点
- 流感疫苗接种与首发AMI风险降低相关(AOR=0.85,95%CI 0.82-0.88)。
- 保护作用在流行前、流行期和流行后均一致,且接种后短期即出现并持续。
- 肺炎球菌疫苗未显示与AMI风险的负相关(AOR=1.10,95%CI 1.06-1.15)。
核心结论
- 结果与流感疫苗对一般人群AMI的中度保护作用相符,主要体现于一级预防,但未测量混杂偏倚可能部分解释该结果。
研究设计与样本
- 基于BIFAP数据库的人群病例对照研究,覆盖2001-2015年,对象为40-99岁患者。
- 每个AMI病例随机匹配5名对照,按 exact 年龄、性别和索引日期个体匹配。
主要发现
- 流感疫苗接种与AMI风险的调整OR为0.85(95%CI 0.82-0.88)。
- 未观察到性别、年龄和背景心血管风险对效果的修饰。
- 流行前期AOR=0.87(95%CI 0.79-0.95),流行期AOR=0.89(95%CI 0.82-0.96),流行后期AOR=0.83(95%CI 0.79-0.87)。
- 肺炎球菌疫苗与AMI无负相关(AOR=1.10;95%CI 1.06-1.15)。
关键数值与推荐
- 疫苗接种定义为同一季节索引日期前至少14天有记录的流感疫苗接种。
- 采用条件logistic回归计算调整OR及95%CI,分析总体及每个研究年度的三个流行期。
临床怎么用
- 在一般人群中,流感疫苗接种可能与首发AMI风险中度降低相关,支持其在一级预防中的潜在作用。
- 临床决策时应考虑未测量混杂因素可能部分解释观察到的保护性关联。
局限性
- 未测量混杂因素可能部分解释结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the relationship between influenza vaccination and risk of a first acute myocardial infarction (AMI) in the general population by different epidemic periods. METHODS: This is a population-based case-control study carried out in BIFAP (Base de datos para la investigación farmacoepidemiológica en atención primaria), over 2001-2015, in patients aged 40-99 years. Per each incident AMI case, five controls were randomly selected, individually matched for exact age, sex and index date (AMI diagnosis). A patient was considered vaccinated when he/she had a recorded influenza vaccination at least 14 days before the index date within the same season. The association between influenza vaccination and AMI risk was assessed through a conditional logistic regression, computing adjusted ORs (AOR) and their respective 95% CIs. The analysis was performed overall and by each of the three time epidemic periods per study year (pre-epidemic, epidemic and postepidemic). RESULTS: We identified 24 155 AMI cases and 120 775 matched controls. Of them, 31.4% and 31.2%, respectively, were vaccinated, yielding an AOR of 0.85 (95% CI 0.82 to 0.88). No effect modification by sex, age and background cardiovascular risk was observed. The reduced risk of AMI was observed shortly after vaccination and persisted over time. Similar results were obtained during the pre-epidemic (AOR=0.87; 95% CI 0.79 to 0.95), epidemic (AOR=0.89; 95% CI 0.82 to 0.96) and postepidemic (AOR=0.83; 95% CI 0.79 to 0.87) periods. No association was found with pneumococcal vaccine (AOR=1.10; 95% CI 1.06 to 1.15). CONCLUSIONS: Results are compatible with a moderate protective effect of influenza vaccine on AMI in the general population, mostly in primary prevention, although bias due to unmeasured confounders may partly account for the results.
引用
- de Abajo FJ, Rodríguez-Martín S, Barreira D, et al. Influenza vaccine and risk of acute myocardial infarction in a population-based case-control study. Heart. 2022. PMID: 34645644. doi:10.1136/heartjnl-2021-319754
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。